Dr. Yang Shen 沈扬
Chief Physician
Department of Gynecologic Oncology Surgery, Jiangsu Cancer Hospital, Nanjing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Standardized treatment of common gynecologic tumors, including cervical cancer, ovarian cancer, and endometrial cancer.
Dr. Shen holds a doctorate in oncology and serves as a Chief Physician. Dr. Shen has extensive clinical experience in the comprehensive and individualized treatment of common gynecologic tumors, including cervical, ovarian, and endometrial cancers.
Name order: in Chinese the family name comes first (Shen Yang). Papers usually list the name as Yang Shen or Shen Y.
Selected publications
16 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- Target Oncol, 2023 (senior author): Efficacy and Safety of Niraparib as First-Line Maintenance Treatment for Patients with Advanced Ovarian Cancer: Real-World Data from a Multicenter Study in China. PubMed 37847485
- Drug Des Devel Ther, 2023 (senior author): Efficacy and Safety of Anlotinib in Overall and Disease-Specific Advanced Gynecological Cancer: A Real-World Study. PubMed 37435095
- Med Sci Monit, 2021 (senior author): Retracted: Costunolide Inhibits the Growth of OAW42-A Multidrug-Resistant Human Ovarian Cancer Cells by Activating Apoptotic and Autophagic Pathways, Production of Reactive Oxygen Species (ROS), Cleaved Caspase-3 and Cleaved Caspase-9. PubMed 34815377
- J Ovarian Res, 2021 (first author): LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis. PubMed 34789303
- Transl Cancer Res, 2021 (first author): Effect of Rho GTPase activating protein 9 combined with preoperative ratio of platelet distribution width to platelet count on prognosis of patients with serous ovarian cancer. PubMed 35116301
- Ann Palliat Med, 2021 (senior author): Correlation analysis of Ki67 and CK7 expression with clinical characteristics and prognosis of postoperative cervical adenocarcinoma patients. PubMed 34628880
- Med Sci Monit, 2019 (senior author): Costunolide Inhibits the Growth of OAW42-A Multidrug-Resistant Human Ovarian Cancer Cells by Activating Apoptotic and Autophagic Pathways, Production of Reactive Oxygen Species (ROS), Cleaved Caspase-3 and Cleaved Caspase-9. PubMed 31043579
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion